Concourse Financial Group Securities’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10225 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10238 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 9881 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 9546 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 9320 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9097 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 8867 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 8652 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 8328 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 8336 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8158 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8012 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7836 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 7678 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7386 |
|